Information will be displayed around Dr. Mikhail Blagosklonny. One drug that the Dr. has worked with is Sirolimus also known as Rapamycin. This drug has received fame as a cancer drug. It was first time isolated in 1972 on Easter Island from a bacterium found. This is a drug does a couple things. One thing it does is stop rejection of organ transplant. Also, it treats a rare type of cancer disease and it is used as a coating for stents of coronary. This was known as a wonder drug that was first used as an agent that was anti-fungal. It had great properties that were antiprolifearative and immunosuppressive. Read more about Mikhail on Crunchbase.
The Dr. had played a great role in this drug. He had gained game by advocating Rapamycin. He did this for increasing a human being’s life span. His giving to this science field is both unparalleled and immense. Dr. Mikhail Blagosklonny, is a professor of Oncology in Buffalo, New York at the Rosewell Park Cancer Institute. Currently, he has published and conducting lengthy research of aging.
There are different reasons why Rapamycin is a great rare medicine type. One reason, is because it has treated a type of rare disease with severe side effects called hemolytic-uremic syndrome. This disease is caused by a mixture of anemia, a low count of platelets, and kidney failure. The only corrective measure in this disease is to undergo kidney transplantation. When this is done calcineurin inhibitors need to be taken. Also, Rapamycin helps in cancer treatment as well. It has the capacity to enhance the body’s immune response to the tumors. Also, it can promote the regression of tumors. This being said it has a great tool in lowering the cancer risk in patients having organ transplants. View Mikhail’s profile on Google Scholar.
Now some information about the plans that Dr. Blagosklonny has in store. One such thing is to continue forming research which will keep on being useful with the field of oncology. The Dr. will also figure out a method that cancer cells can be taken out in the body without breaking normal cells.
The one’s in particular that are crucial more specifically to the recovering of the body and mind after many years of months of cancer treatment. Currently, the Dr. has made a lot of progress in his interest. He has hope that the things he found will give inspiration over the world for more studies.
Health care costs have been on the increase in the U.S. An extra $933 billion in 2013 was spent on health care compared to 1996. This has been attributed to the increase in charges on patients’ care. The growth in the general population, as well as aging, has increased health care spending.
Researchers are now focused on breaking down the spending by disease, and the different factors that lead to an increase in disease prevalence. Diabetes recorded the highest increase in annual health care spending. Most of the spending was on pharmaceuticals. Lower back pains, as well as neck pains, followed second in the list. The amount of money spent on taking care of these ailments increased per annum as much as the prevalence remained the same. An increase of 8.5% was recorded in inpatient care annually.
Annual spending on inpatient services increased from $258 billion to a whopping $697 billion. This was despite the efforts made to reduce that amount by $201 billion. The increase in spending was ironic since patients recorded shorter stays in hospitals. Spending went up even though hospitals provided all the necessary care in fewer days.
High drug prices have been justified by having to create savings through prevention of hospitalizations. This has not been convincing enough since health care spending keeps increasing.
Eric Lefkofsky is the CEO and co-founder of Tempus. The company’s focus is to come up with technological advancements to fight cancer. Eric Lefkofsky and his wife are renowned philanthropists to causes that are aimed at cancer research. Last year they donated about $3 million to various research institutes that are aimed towards fighting cancer.
Eric Lefkofsky founded the Lefkofsky Family Foundation in 2006. This charitable foundation aims at positively impacting the lives of the communities that they serve. He serves at the Lurie Children’s Hospital of Chicago, The Museum of Science and Industry, The Art Institute of Chicago, and the World Business Chicago as a Trustee. Lefkofsky also serves as a professor at the University of Chicago. He is also a writer, he authored the book Accelerated Disruption. Lefkofsky studied at the University of Michigan’s school of law and got his Juris Doctor.
Cancer diseases have been a major reason behind the increase in national mortality rate for so long. For most people, a cancer diagnosis means putting one’s affairs in order and waiting for death to catch up with them but that is not the case anymore. Rutgers Cancer Institute of New Jersey is the new sense of hope for many of the cancer patients in the world. The institute is the only designated comprehensive cancer institute in the whole state. According to Yahoo.com, it is also a research facility that is geared towards better diagnosis, treatment and care of cancer patients. They translate the research carried out in their laboratories and use it in their clinical practice to come up with better ways of treatment. The hospital works closely with other cancer treatment centers and research facilities in order to ensure that it covers a wider range of patients in their research. This has further been made possible by the most recent pledge from Omar Boraie’s family.
The cancer institute came up with an idea to gain endorsement on their projects where they have eighteen chairs heading their research facilities that are in turn supported financially by the anonymous donors providing a matching donation of $1.5 million. According to the article on Newswise, Omar Boraie’s family made such a donation to the recently established Omar Boraie chair. The money will go into the research of genetic treatment of cancer. The treatment will target the precise treatment of cancer where it will give an individualistic approach to the method of treatment. The study will eventually categorize cancers according to sub-groups of people with different genes but similar characteristics.
According to the Wall Street Journal, the institution’s doctor Shridar Ganesan who also works as associate professor of medicine and pharmacology at Rutgers Robert Wood Johnson Medical School has been named the chair. He describes cancer as a set of diseases rather than a single disease. He says that this method of treatment will study cancers according to their unique symptoms hence people can get individualistic diagnosis and therapy. To Boraie, this is hope for all the people in the world with unique cancers and those whose cancer has become unresponsive to various forms of treatment or have limited treatment options. Boraie hopes that this will bring change in the world so people will no longer succumb to cancer. It will also open the door to research on treatment of other similar diseases that could display uniqueness from one person to the other.
Read More: http://www.nytimes.com/2005/03/06/realestate/at-two-extremes-of-a-housing-market.html